InsiderTrades

Form 4 for KPRX KIORA PHARMACEUTICALS INC

Accepted 2023-10-03 00:00:00 ET · period of report 2023-09-29 · accession 0001372514-23-000149 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-10-03 2023-09-29 KPRX Daniels Eric Joseph Chief Development Off A - Grant $0.00 +62.5K 88.3K +242% $0
D 2023-10-03 2023-09-29 KPRX Daniels Eric Joseph Chief Development Off A - Grant $0.00 +125.0K 125.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-09-29 A A 62,500 $0.00 88,338 D — — (F1) Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to twenty-five percent (25%) of the shares immediately upon grant, and twenty-five percent (25%) on each of September 29, 2024, September 29, 2025 and September 29, 2026, subject to the reporting person's continuous service through each such vesting date.
2 Derivative Stock Option (right to buy) 2023-09-29 A A 125,000 $0.00 125,000 D $0.57 · 2023-09-29 to 2033-09-29 125,000 Common Stock (F2) The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to twenty-five percent (25%) of the shares underlying the Option upon grant on September 29, 2023, twenty-five percent (25%) on September 29, 2024 and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.